Cargando…
The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options
The incidence of melanoma has been increasing at a rapid rate, with 4%–11% of all melanoma recurrences presenting as in-transit disease. Treatments for in-transit melanoma of the extremity are varied and include surgical excision, lesional injection, regional techniques and systemic therapies. Excis...
Autores principales: | Gabriel, Emmanuel, Skitzki, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586763/ https://www.ncbi.nlm.nih.gov/pubmed/26140669 http://dx.doi.org/10.3390/cancers7030830 |
Ejemplares similares
-
Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma
por: Gabriel, Emmanuel M., et al.
Publicado: (2020) -
Improving IBD outcomes in the era of many treatment options
por: Kobayashi, Taku, et al.
Publicado: (2023) -
Melanoma: the role of surgery in the era of new therapies
por: Mozzillo, Nicola, et al.
Publicado: (2014) -
Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes
por: Belkacemi, Yazid, et al.
Publicado: (2018) -
Survival in melanoma brain metastases in the era of novel systemic therapies
por: Merola, Joseph P, et al.
Publicado: (2020)